Third Rock Ventures V, L.P.
RAPPThird Rock Ventures V, L.P. serves as 10 percent owner at Rapport Therapeutics, Inc. Common Stock (RAPP). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Third Rock Ventures V, L.P.'s Insider Trading at Rapport Therapeutics, Inc. Common Stock (RAPP)
Buys
0 · $0.00
Sells
4 · $34.39M
Total Shares Bought
0
Total Shares Sold
854,708
Third Rock Ventures V, L.P.'s Insider Trading at Septerna Inc (SEPN)
Buys
1 · $11.70M
Sells
1 · $7.40M
Total Shares Bought
650,000
Total Shares Sold
147,200
Related Insiders
Krishnaswamy Yeleswaram
officer: Chief Development Officer
RAPPSell · Aug 26, 2026
Abraham Ceesay
director, officer: Chief Executive Officer
RAPPSell · Aug 26, 2026
RA CAPITAL MANAGEMENT, L.P.
director, 10 percent owner:
SEPNSell · Aug 14, 2026
Elizabeth Bhatt
President and COO
SEPNSell · Aug 13, 2026
Daniel D. Long
SVP, Drug Discovery
SEPNSell · Aug 5, 2026
Cheryl Gault
officer: Chief Operating Officer
RAPPSell · Jul 1, 2026
Samira Shaikhly
officer: Chief People Officer
SEPNSell · Jun 30, 2026
David Bredt
officer: Chief Scientific Officer
RAPPSell · Feb 19, 2026